Galaxy Medicare
September 10, 2025 – September 12, 2025
| Price | ₹51 - ₹54 |
| GMP Rumors * | ₹0 |
|---|---|
| Lot size | 2000 |
| Allotment | Sep 15, 2025 |
| Listing | Sep 17, 2025 |
Galaxy Medicare Lot(s) Distribution
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
| INDIVIDUAL | 2 | 4000 | 216000 | 0 |
| sHNI | 3 | 6000 | 324000 | 0 |
| bHNI | 10 | 20000 | 1080000 | 0 |
Galaxy Medicare Reservation
| Category | Shares Offered | % |
|---|---|---|
| Total | 0 | 100% |
Galaxy Medicare About
IPO Details As per DRHP
| Total Issue | 41,32,000 shares (aggregating up to ₹22.31 Cr) |
| Fresh Issue | 33,08,000 shares (aggregating up to ₹17.86 Cr) |
| Offer for Sale | 8,24,000 shares of ₹10 (aggregating up to ₹4.45 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Share Holding Pre Issue | 1,18,63,983 shares |
| Share Holding Post Issue | 1,54,15,983 shares |
| Market Maker's Portion | 2,08,000 shares |
Galaxy Medicare IPO Reservation
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | Not more than 50.00% of the Net Issue |
| Retail Shares Offered | Not less than 35.00% of the Net Issue |
| NII Shares Offered | Not less than 15.00% of the Net Issue |
Key Performance Indicator (KPI)
Adding soon.Financial Details In Crores
Adding soon.Peer Comparision
Adding soon.Company Overview
Incorporated: July 1992
Business: Manufacturing & exporting medical devices, POP bandages, surgical dressings, wound care solutions, adhesive & compression bandages, gauze products, and orthopedic items.
Brands: POP BAND, POP CAST, G CAST, GYPSOSOFT, GYPSOPLAST, CARETAPE, GYPSOCREPE, CARECREPE, CAREPORE, GYPSONET, GYPSOCHLOR, FIXCAN, etc. (27 registered trademarks in India)
Operations:
Manufacturing & branding under flagship brands
OEM manufacturing (Principal-to-Principal)
Institutional sales via government tenders (GEM Portal)
Exports & trading of surgical dressings and devices
Certifications: ISO 9001:2015, ISO 13485:2016
Market Presence: Supplies across India to government health departments, corporate hospitals, private entities; exports internationally.
Strength
Established Track Record: 30+ years of operation with a well-established reputation and deep customer relationships.
Diversified Product Portfolio: Offers over 27 registered trademarks covering a wide spectrum of medical needs, reducing dependency on any single product.
Multiple Revenue Channels: Balanced revenue streams from branded sales, OEM work, government contracts, and exports.
Weakness
Customer Concentration Risk: Loss of any key customer may significantly impact revenues and profitability.
Raw Material Dependency Risk: Shortage or price rise in raw materials may disrupt supply and margins.
Legal and Compliance Risk: Ongoing legal proceedings could adversely affect reputation and financial condition.
Galaxy Medicare Lead Manager(s)
Galaxy Medicare Address
Plot No-2, Zone D,
Phase A, Mancheswar Industrial Estate
Khurda
Bhubaneshwar, Odisha, 751010
Phone: +91 9937000991
Email: CS@galaxymed.co.in
Website: http://www.galaxy.in/